2000
Testing for Hereditary Breast and Ovarian Cancer in the Southeastern United States
Miron A, Schildkraut J, Rimer B, Winer E, Skinner C, Futreal P, Culler D, Calingaert B, Clark S, Marcom P, Iglehart J. Testing for Hereditary Breast and Ovarian Cancer in the Southeastern United States. Annals Of Surgery 2000, 231: 624-634. PMID: 10767783, PMCID: PMC1421049, DOI: 10.1097/00000658-200005000-00002.Peer-Reviewed Original ResearchConceptsProphylactic surgeryPreventive surgeryOvarian cancerFree genetic testingProspective clinical trialsBreast cancer patientsHereditary breast cancerPositive test resultsUncertain clinical significanceMore heterogeneous populationsBaseline characteristicsCancer patientsBaseline questionnaireClinical trialsTime of entryBreast cancerClinical significanceHeterogeneous syndromeSurgeryHereditary breastNumber of womenDeleterious gene mutationsBRCA2 genesGenetic testingSpecial populations
1999
Modeling Risk of Breast Cancer and Decisions about Genetic Testing
Parmigiani G, Berry D, Iversen E, Müller P, Schildkraut J, Winer E. Modeling Risk of Breast Cancer and Decisions about Genetic Testing. Lecture Notes In Statistics 1999, 140: 133-203. DOI: 10.1007/978-1-4612-1502-8_3.Peer-Reviewed Original ResearchBreast cancerFamily historyGenetic susceptibilityGenetic testingPreventive treatment decisionsPatient counselingRisk factorsTreatment decisionsClinical OncologyRelated cancersBRCA2 genesCancerMedical decision makingIndividualized informationRiskAccurate assessmentPatientsDuke UniversityRisk communicationBreastCliniciansEpidemiologyResearch UnitSusceptibilityOncology